BioSpace News Archive

The report, PARP (poly ADP-ribose polymerase) inhibitors market 2019-2023, has been added to Technavio’s catalog.

Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Gentamicin Sulfate Cream USP, 0.1% (gentamicin base).

Immunomic Therapeutics, Inc. will present data on its investigational nucleic acid platform, UNITE (UNiversal Intracellular Targeted Expression), that elicits potent immune responses when used with its investigational UNITE vaccine, ITI-3000, in mice

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its common stock will continue trading on The Nasdaq Capital Market under the symbol “DMTK.”

CareCentrix, the leading provider of home-based, post-acute care solutions celebrates the success of its Women’s Network, an employee resource group aimed at promoting the advancement and inclusion of women leaders within CareCentrix

The sessions may be accessed from the “Investors & Media” page of Regeneron’s website at http://investor.regeneron.com/events-and-presentations.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the third quarter ended September 30, 2019, after the close of the stock market on Wednesday, October 30, 2019.

Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that Dr. Torsten Madsen, acting Chief Medical Officer will be presenting preclinical data highlighting the strong association between bacteria-derived metabolites and autism spectrum disorder (ASD) at the Society for Neuroscience 2019 Annual Meeting on Saturday, October 19, 2019 in Chicago, IL.

The market will accelerate at a CAGR of over 5% between 2019-2023

The Multiple Myeloma Research Foundation (MMRF) was honored to have General Colin L. Powell (Ret.) as the keynote speaker at the annual MMRF Chicago Awards Dinner fundraiser at the Four Seasons Chicago on October 17, 2019.